In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Twist Bioscience nabs $50mm in late-stage financing

Executive Summary

Twist Bioscience Corp. (synthetic DNA) raised $50mm in a late-stage private placement. According to the Form D, one investor participated and the company could raise up to $85mm in the round. With the new funds, Twist has now raised nearly $260mm in venture rounds since its Series A back in 2013.
Deal Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Synthesis Technologies, Production Processes
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register